<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>11(1)</volume><submitter>Kleiman E</submitter><funding>JSR Life Sciences, LLC</funding><pubmed_abstract>Extracellular adenosine suppresses T cell immunity in the tumor microenvironment and in vitro treatment of memory T cells with adenosine can suppress antigen-mediated memory T cell expansion. We describe utilizing the recall antigen assay platform to screen small molecule drug off-target effects on memory T cell expansion/function using a dosing regimen based on adenosine treatment. As a proof of principle, we show low dose GS-5734, a monophosphoramidate prodrug of an adenosine analog, does not alter memory T cell recall at lower doses whereas toxicity observed at high dose favors antigen-specific memory T cell survival/proliferation over non-specific CD8&lt;sup>+&lt;/sup> T cells. Conversely, parent nucleoside GS-441524 at high dosage does not result in cellular toxicity and reduces antigen-spe</pubmed_abstract><journal>Scientific reports</journal><pagination>9561</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8100288</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Adenosine-related small molecules show utility of recall antigen assay to screen compounds for off-target effects on memory T cells.</pubmed_title><pmcid>PMC8100288</pmcid><pubmed_authors>Kleiman E</pubmed_authors><pubmed_authors>Magcase D</pubmed_authors><pubmed_authors>Mao B</pubmed_authors><pubmed_authors>Daftarian PM</pubmed_authors><pubmed_authors>Sierra G</pubmed_authors><pubmed_authors>George MV</pubmed_authors></additional><is_claimable>false</is_claimable><name>Adenosine-related small molecules show utility of recall antigen assay to screen compounds for off-target effects on memory T cells.</name><description>Extracellular adenosine suppresses T cell immunity in the tumor microenvironment and in vitro treatment of memory T cells with adenosine can suppress antigen-mediated memory T cell expansion. We describe utilizing the recall antigen assay platform to screen small molecule drug off-target effects on memory T cell expansion/function using a dosing regimen based on adenosine treatment. As a proof of principle, we show low dose GS-5734, a monophosphoramidate prodrug of an adenosine analog, does not alter memory T cell recall at lower doses whereas toxicity observed at high dose favors antigen-specific memory T cell survival/proliferation over non-specific CD8&lt;sup>+&lt;/sup> T cells. Conversely, parent nucleoside GS-441524 at high dosage does not result in cellular toxicity and reduces antigen-spe</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 May</publication><modification>2026-05-08T09:39:49.668Z</modification><creation>2022-02-10T09:33:20.103Z</creation></dates><accession>S-EPMC8100288</accession><cross_references><pubmed>33953256</pubmed><doi>10.1038/s41598-021-88965-3</doi></cross_references></HashMap>